Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

被引：0
作者：
Nicholas H. B. Schräder
Emily S. Gorell
Roy E. Stewart
José C. Duipmans
Nicole Harris
Victoria A. Perez
Jean Y. Tang
André P. Wolff
Marieke C. Bolling
机构：
[1] University Medical Centre Groningen,Department of Dermatology
[2] University of Groningen,Department of Dermatology
[3] University of Cincinnati College of Medicine,Department of Dermatology
[4] Stanford University School of Medicine,Department of Health Sciences, Community and Occupational Medicine
[5] University of Groningen,Anaesthesiology Pain Centre, Department of Anaesthesiology
[6] University Medical Centre Groningen,undefined
[7] Columbia University School of Medicine,undefined
[8] University Medical Centre Groningen,undefined
[9] University of Groningen,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Epidermolysis bullosa; Cannabinoid-based medicines; Symptom alleviation; Patient driven research; Genodermatoses; Survey; Pain; Itch; Wounds;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 299 条
[41]  
Schräder NHB(2017)Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations Am J Public Health 107 e1-1349
[42]  
Duipmans JC(2019)Benefit of tetrahydrocannabinol versus cannabidiol for common palliative care symptoms J Palliat Med 22 1180-8
[43]  
Molenbuur B(2016)Multidimensional diagnostic criteria for chronic pain: introduction to the ACTTION–American Pain society pain taxonomy (AAPT) J Pain 17 T1-851
[44]  
Wolff AP(2014)Burden of itch in epidermolysis bullosa Br J Dermatol 171 73-1130
[45]  
Jonkman MF(2008)Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews Acta Derm Venereol 88 143-63
[46]  
Martinez AE(2015)Evaluation of treatments for pruritus in epidermolysis bullosa Pediatr Dermatol 32 628-355
[47]  
Pacher P(2014)Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa Orphanet J Rare Dis 9 76-180
[48]  
Bátkai S(2020)Topical cannabis-based medicines—a novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: an open label trial Int Wound J 17 1508-S222
[49]  
Kunos G(2021)The therapeutic potential of cannabinoids for integumentary wound management Exp Dermatol 30 201-1429
[50]  
Bíró T(2009)Cannabinoids as novel anti-inflammatory drugs Future Med Chem 1 1333-262
12345678910